This is a single-arm, multi-center clinical trial to assess the efficacy of a new medicine called romiplostim as a supportive care measure in patients with a new diagnosis of Ewing sarcoma who are receiving interval-compressed chemotherapy.
Study Details
Internal Title:
Romiplostim-BT-2201
PCH IRB Number:
IRB-25-227
Clinical Trials Government Identifier:
NCT07048249
Diagnoses & Treatments:
Cancer; Ewing Sarcoma; Chemotherapy Induced Thrombocytopenia (CIT)
Study Type:
Clinical Trial
Eligibility:
> 1 year old, new diagnosis of Ewing sarcoma
Enrollment Status:
Opening Soon